Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8398988 | Mitochondrion | 2016 | 35 Pages |
Abstract
Friedreich's ataxia is an autosomal recessive neurodegenerative disorder associated with an unstable GAA trinucleotide repeat expansion in the first intron of the frataxin gene. This mutation leads to a decrease and partial loss of function of frataxin, a mitochondrial protein involved in heme biosynthesis and cellular iron homeostasis. Since no effective therapy exists for Friedreich's ataxia, new insights into frataxin regulated genes and associated cellular pathways will provide a better understanding of the molecular mechanisms underlying this debilitating condition. In this study, we demonstrate that frataxin regulates the expression of genes involved in interferon-induced apoptosis, DNA damage and blood clotting regulation. This work provides valuable insight into the regulatory network of frataxin and may open new avenues for gene therapy of Friedreich's ataxia.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biophysics
Authors
Noëlia Sanchez, Pierre Chapdelaine, Joël Rousseau, Frédéric Raymond, Jacques Corbeil, Jacques P. Tremblay,